Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1993-11-4
|
pubmed:abstractText |
We retrospectively reviewed the effects of intravenous gamma-globulin (IVGG) re-treatment of 13 children with Kawasaki disease and persistent or recrudescent fever. Fever and mucocutaneous inflammation resolved within 48 hours in nine patients; fever abated in two other children after a third course of IVGG. We conclude that IVGG re-treatment of Kawasaki disease appears to be safe and may improve the clinical course.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-3476
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
123
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
657-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8410524-Child, Preschool,
pubmed-meshheading:8410524-Female,
pubmed-meshheading:8410524-Humans,
pubmed-meshheading:8410524-Immunoglobulins, Intravenous,
pubmed-meshheading:8410524-Male,
pubmed-meshheading:8410524-Mucocutaneous Lymph Node Syndrome,
pubmed-meshheading:8410524-Retrospective Studies,
pubmed-meshheading:8410524-Treatment Failure
|
pubmed:year |
1993
|
pubmed:articleTitle |
Gamma globulin re-treatment in Kawasaki disease.
|
pubmed:affiliation |
Department of Medicine, Children's Hospital, Boston, Massachusetts 02115.
|
pubmed:publicationType |
Journal Article
|